Microarray Analysis Market

Executive Summary

Microarray Analysis Market was valued at US $4.36 billion in 2021 and is projected to grow at 9.23% CAGR over the forecast period to reach US $7.40 billion by 2027. Microarray Analysis Market represented US $0.71 billion opportunity over 2019-2021 and estimated to create US $3.04 billion opportunity in 2027 over 2021.

Microarray Analysis from Consainsights analyses the Microarray Analysis Market in the Life Sciences industry over the forecast period to 2027.

Microarray Analysis research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Microarray Analysis segmentation includes Product and Service, Type, Application, End User, Region and Geography.

Based on the Product and Service, the Microarray Analysis analysis covers Consumables, Software and Services, Instruments.

In Product and Service segment, Consumables segment has highest cagr growth of 8.17%.

Based on the Type, the Microarray Analysis analysis covers Dna Microarrays, Protein Microarrays, Other Microarrays.

In Type segment, Dna Microarrays segment has highest cagr growth of 8.17%.

Based on the Application, the Microarray Analysis analysis covers Research Applications, Drug Discovery, Disease Diagnostics, Other Applications.

In Application segment, Research Applications segment has highest cagr growth of 8.17%.

Based on the End User, the Microarray Analysis analysis covers Research & Academic Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Other End Users.

In End User segment, Research & Academic Institutes segment has highest cagr growth of 8.17%.

Based on the Region, the Microarray Analysis analysis covers North America, Europe, Asia Pacific, Rest of the World.

In Region segment, North America segment has highest cagr growth of 8.17%.

Based on the region, the Microarray Analysis analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Thermo Fisher Scientific, Agilent Technologies, Illumina, Perkinelmer, Inc., Merck KGaA, GE Healthcare, Molecular Devices (A Subsidiary of Danaher), Arrayit Corporation, Bio-Rad Laboratories, Microarrays, Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product and Service

Introduction

In 2021, Consumables segment has the highest revenue of US $2.03 billion and is expected to grow at CAGR of 8.17% by 2027 Consumables segment has highest cagr growth of 8.17%.

Consumables

Consumables segment was valued at US $1.70 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $3.45 billion by 2027. Consumables segment represented US $0.33 billion opportunity over 2019-2021 and estimated to create US $1.42 billion opportunity in 2027 over 2021.

Software and Services

Software and Services segment was valued at US $1.24 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $2.51 billion by 2027. Software and Services segment represented US $0.24 billion opportunity over 2019-2021 and estimated to create US $1.03 billion opportunity in 2027 over 2021.

Instruments

Instruments segment was valued at US $0.71 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $1.44 billion by 2027. Instruments segment represented US $0.14 billion opportunity over 2019-2021 and estimated to create US $0.59 billion opportunity in 2027 over 2021.

Type

Introduction

In 2021, Protein Microarrays segment has the highest revenue of US $2.13 billion and is expected to grow at CAGR of 8.17% by 2027 Dna Microarrays segment has highest cagr growth of 8.17%.

Dna Microarrays

Dna Microarrays segment was valued at US $1.49 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $3.01 billion by 2027. Dna Microarrays segment represented US $0.29 billion opportunity over 2019-2021 and estimated to create US $1.24 billion opportunity in 2027 over 2021.

Protein Microarrays

Protein Microarrays segment was valued at US $1.78 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $3.62 billion by 2027. Protein Microarrays segment represented US $0.34 billion opportunity over 2019-2021 and estimated to create US $1.49 billion opportunity in 2027 over 2021.

Other Microarrays

Other Microarrays segment was valued at US $0.38 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $0.77 billion by 2027. Other Microarrays segment represented US $0.07 billion opportunity over 2019-2021 and estimated to create US $0.32 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Research Applications segment has the highest revenue of US $1.92 billion and is expected to grow at CAGR of 8.17% by 2027 Research Applications segment has highest cagr growth of 8.17%.

Research Applications

Research Applications segment was valued at US $1.61 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $3.25 billion by 2027. Research Applications segment represented US $0.31 billion opportunity over 2019-2021 and estimated to create US $1.34 billion opportunity in 2027 over 2021.

Drug Discovery

Drug Discovery segment was valued at US $1.00 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $2.02 billion by 2027. Drug Discovery segment represented US $0.19 billion opportunity over 2019-2021 and estimated to create US $0.83 billion opportunity in 2027 over 2021.

Disease Diagnostics

Disease Diagnostics segment was valued at US $1.03 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $2.09 billion by 2027. Disease Diagnostics segment represented US $0.20 billion opportunity over 2019-2021 and estimated to create US $0.86 billion opportunity in 2027 over 2021.

Other Applications

Other Applications segment was valued at US $0.02 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $0.04 billion by 2027. Other Applications segment represented US $0.00 billion opportunity over 2019-2021 and estimated to create US $0.02 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Research & Academic Institutes segment has the highest revenue of US $2.38 billion and is expected to grow at CAGR of 8.17% by 2027 Research & Academic Institutes segment has highest cagr growth of 8.17%.

Research & Academic Institutes

Research & Academic Institutes segment was valued at US $1.99 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $4.04 billion by 2027. Research & Academic Institutes segment represented US $0.38 billion opportunity over 2019-2021 and estimated to create US $1.66 billion opportunity in 2027 over 2021.

Pharmaceutical & Biotechnology Companies

Pharmaceutical & Biotechnology Companies segment was valued at US $1.11 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $2.26 billion by 2027. Pharmaceutical & Biotechnology Companies segment represented US $0.22 billion opportunity over 2019-2021 and estimated to create US $0.93 billion opportunity in 2027 over 2021.

Diagnostic Laboratories

Diagnostic Laboratories segment was valued at US $0.44 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $0.89 billion by 2027. Diagnostic Laboratories segment represented US $0.09 billion opportunity over 2019-2021 and estimated to create US $0.37 billion opportunity in 2027 over 2021.

Other End Users

Other End Users segment was valued at US $0.10 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $0.21 billion by 2027. Other End Users segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.09 billion opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $1.93 billion and is expected to grow at CAGR of 8.17% by 2027 North America segment has highest cagr growth of 8.17%.

North America

North America segment was valued at US $1.62 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $3.29 billion by 2027. North America segment represented US $0.31 billion opportunity over 2019-2021 and estimated to create US $1.35 billion opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $0.97 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $1.97 billion by 2027. Europe segment represented US $0.19 billion opportunity over 2019-2021 and estimated to create US $0.81 billion opportunity in 2027 over 2021.

Asia Pacific

Asia Pacific segment was valued at US $0.95 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $1.93 billion by 2027. Asia Pacific segment represented US $0.18 billion opportunity over 2019-2021 and estimated to create US $0.79 billion opportunity in 2027 over 2021.

Rest of the World

Rest of the World segment was valued at US $0.11 billion in 2019 and is projected to grow at 8.17% CAGR over the forecast period to reach US $0.22 billion by 2027. Rest of the World segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.09 billion opportunity in 2027 over 2021.